Aegerion Pharmaceuticals Announces Webcast of Investor Presentations at Upcoming Conferences

Aegerion Pharmaceuticals, Inc. Logo

CAMBRIDGE, Mass., Nov. 14, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Jefferies 2013 Global Healthcare Conference in London. Mark Fitzpatrick, CFO of Aegerion, is scheduled to present on Thursday, November 21, 2013 at 10:00 a.m. GMT (5:00 a.m. EST).

Aegerion will also participate in the Deutsche Bank BioFEST Conference in Boston. Marc Beer, CEO of Aegerion, is scheduled to present on Tuesday, December 3, 2013 at 1:05 p.m. EST.

The presentations will be webcast live and may be accessed for up to 30 days following the conference by visiting the "Investors" section of Aegerion's website,

About Aegerion Pharmaceuticals

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases. For more information about the company, please visit

CONTACT: Aegerion Pharmaceuticals, Inc. Amanda Murphy Manager, Investor Relations 857-242-5024

Source:Aegerion Pharmaceuticals, Inc.